Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma × Medroxyprogesterone Acetate × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 2 Vitamin D Deficiency 1 Polycystic Ovary Syndrome 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1 Endometrial Hyperplasia 1 Endometrial Adenocarcinoma 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

entinostat 1 Medroxyprogesterone Acetate 1 Hysterectomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03018249 2021-11-16

Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer

National Cancer Institute (NCI)

Phase EARLY_PHASE1 Completed

50 enrolled 12 charts

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡